Mapletree Commercial Trust (SGX:N2IU)’s revenue/NPI rose 1.1% y-o-y/0.4% y-o-y in 2Q22, but was lower at 3.7% q-o-q/4.1% q-o-q. The results were in line to consensus’ and our estimates, and with 1H22 revenue/NPI/DPU at 47% of our FY22E, we have kept our forecasts unchanged.
We see a stronger 2H22, underpinned by rising office demand, and improvement in VivoCity’s operating metrics alongside a gradual reopening. Mapletree Commercial Trust's valuations are undemanding at 4.5% dividend yield, with better DPU visibility from its MBC assets, and added traction from VivoCity’s recovery into the coming quarters.
We maintain our forecasts and S$2.35 DDM-based target price (COE: 5.9%, 2.0%) for Mapletree Commercial Trust.
Better Occupancies, Strong Office Demand
The stronger y-o-y performance in 1H22, with revenue and NPI up 11.5% y-o-y and 10.7% y-o-y, was from lower rental rebates (~S$18m versus S$40.5m for FY21) and the compensation received from a lease pre-termination at mTower.
Mapletree Commercial Trust's portfolio occupancy climbed to 93.3% (from 92.6% in 1Q22) with improvements across all its assets, except Mapletree Anson (from 99.2% to 93.9%), but its committed occupancy is higher at 97.0%.
Against strong demand tailwinds, its remaining FY22 office/business park leases (10.3%) were de-risked, with rental reversion at +1.5% (from +0.4% in 2H21).
VivoCity’s Reversion at +3.5%, Flattish Outlook
Revenue/NPI at VivoCity fell 20.5% h-o-h/22.7% h-o-h in 1H22, but it was up 2.6% q-o-q/4.0% q-o-q in 2Q22, on the back of higher behind Frasers Centrepoint Trust (SGX:J69U) (with tenant sales at 93-98%).
Retail rental reversion at +3.5% (from -9.6% in 2H21) was helped by the new Dyson lease (at a high single-digit). We think reversions will likely be flattish in 2H22, with upside risk from further easing in capacities.
Sound Balance Sheet, More Resilient AUM
Mapletree Commercial Trust's AUM was up 0.5% to S$8.8b, with a change of valuers rates and a limited sponsor Singapore pipeline.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....